PWMG
PCVX icon

Private Wealth Management Group’s Vaxcyte PCVX Stock Holding History

Private Wealth Management Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Hold
196
– – ﹤0.01% 542
2026
Q1 		$11.4K Hold
196
– – ﹤0.01% 490
2025
Q4 		$9.04K Buy
196
+11
+6% +$492 ﹤0.01% 542
2025
Q3 		$6.66K Buy
185
+165
+825% +$5.47K ﹤0.01% 678
2025
Q2 		$651 Sell
20
-16
-44% -$525 ﹤0.01% 1369
2025
Q1 		$1.36K Sell
36
-7
-16% -$560 ﹤0.01% 1189
2024
Q4 		$3.52K Buy
43
+7
+19% +$695 ﹤0.01% 883
2024
Q3 		$4.11K Buy
36
+20
+125% +$1.8K ﹤0.01% 806
2024
Q2 		$1.21K Hold
16
– – ﹤0.01% 1222
2024
Q1 		$1.09K Hold
16
– – ﹤0.01% 1233
2023
Q4 		$1K Buy
+16
New +$831 ﹤0.01% 1269

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Private Wealth Management Group's PCVX Position: Q2 2026 in Review

Private Wealth Management Group held its Vaxcyte (PCVX) position steady in Q2 2026 at 196 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

Private Wealth Management Group first reported a position in PCVX in Q4 2023 and has held it in 11 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Private Wealth Management Group held 196 shares of Vaxcyte worth $11.4K as of Q2 2026.
  • Private Wealth Management Group left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #542 holding.
  • Private Wealth Management Group first reported a position in Vaxcyte in Q4 2023 and has held it in 11 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.